These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18316847)

  • 1. Antiviral benefits for HIV-infected patients : the crucial role & multiple determinants of adherence.
    Cuzin L
    Indian J Med Res; 2008 Jan; 127(1):7-9. PubMed ID: 18316847
    [No Abstract]   [Full Text] [Related]  

  • 2. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
    Pozniak A; Gazzard B; Anderson J; Babiker A; Churchill D; Collins S; Fisher M; Johnson M; Khoo S; Leen C; Loveday C; Moyle G; Nelson M; Peter B; Phillips A; Pillay D; Wilkins E; Williams I; Youle M;
    HIV Med; 2003 Oct; 4 Suppl 1():1-41. PubMed ID: 14511246
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic consideration for the use of antiretroviral agents in the elderly.
    Rhee MS; Greenblatt DJ
    J Clin Pharmacol; 2008 Oct; 48(10):1212-25. PubMed ID: 18812611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal drug treatment regimens for HIV depend on adherence.
    Krakovska O; Wahl LM
    J Theor Biol; 2007 Jun; 246(3):499-509. PubMed ID: 17320115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lack of compliance means no success].
    Kuhlmann B
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():18-9. PubMed ID: 16385864
    [No Abstract]   [Full Text] [Related]  

  • 7. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. There are no paradoxes of adherence and drug resistance to HIV antiretroviral therapy.
    Green DA
    J Antimicrob Chemother; 2004 Sep; 54(3):694; author reply 694-5. PubMed ID: 15282234
    [No Abstract]   [Full Text] [Related]  

  • 9. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Swedish guidelines for antiretroviral treatment of HIV. Good compliance is crucial for a good result].
    Gisslén M; Sönnerborg A
    Lakartidningen; 2002 Oct; 99(43):4263-6. PubMed ID: 12448313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.
    Justesen US
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):20-31. PubMed ID: 16433887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia.
    Pujades-Rodríguez M; Schramm B; Som L; Nerrienet E; Narom P; Chanchhaya N; Ferradini L; Balkan S
    Trop Med Int Health; 2011 Feb; 16(2):205-13. PubMed ID: 21087376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Simply convincing. New fixed combination for HIV therapy].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():20-3. PubMed ID: 16385865
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral regimens for treatment-experienced patients with HIV-1 infection.
    Lagnese M; Daar ES
    Expert Opin Pharmacother; 2008 Apr; 9(5):687-700. PubMed ID: 18345948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do patients fail HIV therapy?
    Waters L; Nelson M
    Int J Clin Pract; 2007 Jun; 61(6):983-90. PubMed ID: 17504360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching antiretroviral therapy: why, when and how.
    Wilkin T; Glesby M; Gulick RM
    IAPAC Mon; 2006 Jul; 12(7):220-9. PubMed ID: 17096494
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of once- and twice-daily dosing regimens on adherence and overall safety.
    Hawkins T
    AIDS Read; 2004 Jun; 14(6):320-2, 324, 329-31, 334-6. PubMed ID: 15243968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence rates and drug-resistant HIV: new data.
    Laurence J
    AIDS Read; 2003 Oct; 13(10):457-8. PubMed ID: 14596222
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven.
    Lucas GM
    J Antimicrob Chemother; 2005 Apr; 55(4):413-6. PubMed ID: 15722389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.
    Sethi AK; Celentano DD; Gange SJ; Moore RD; Gallant JE
    Clin Infect Dis; 2003 Oct; 37(8):1112-8. PubMed ID: 14523777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.